Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
I studied fundamentally 6-days subrenal capsule assay, using human oral cancer transplanted in nude mice. The relative variation of tumor size (delta TS/
TSO
) was calculated as follows; delta TS/
TSO
= (TS6-
TSO
)/
TSO
X 100(%), where TS 6 was the tumor size on day 6 and
TSO
that on day O, and more than a 10% decrease of delta TS/
TSO
in the treated group was considered as positive for chemosensitivity. The chemosensitive rates were 38.0 +/- 8.1% (mean +/- standard deviation) for control, -8.0 +/- 8.5% for 5-FU, 1.8 +/- 16.7 for PEP, 5.0 +/- 9.1% for CDDP, -26 +/- 9.6% for 5-FU + PEP and -17.0 +/- 6.7% for 5-FU + CDDP. A single chemotherapy was negative, but combination chemotherapy was positive and few side effects (body weight loss) was showed. The 6-days
SRC
assay (combined anticancer drugs) appeared to be useful for selecting sensitive drugs for oral cancer patient.
...
PMID:[Experimental chemotherapy using transplantable human oral cancer in nude mice by SRC assay]. 248 5